Navigating the safety of Cenforce 100 in patients with liver or kidney impairment requires a comprehensive understanding of its pharmacokinetics, individual patient factors, and healthcare guidance. While data specific to these populations are limited, cautious use, dosage adjustments, and close monitoring may help mitigate potential risks and optimize therapeutic outcomes. By fostering open communication and collaboration between patients and healthcare providers, we can ensure informed decision-making and promote patient-centered care in the management of erectile dysfunction. https://www.flatmeds.com/product/cenforce-100/